IMITREX (sumatriptan) Coupons, Discounts & Cost

IMITREX (sumatriptan) Coupons, Discounts & Cost
Click to Open Site ( visit store )
0 0
Comments Off
Want to say something? Add Comment 

Imitrex (sumatriptan) Coupons and Discounts

Imitrex (sumatriptan) is an anti-migraine agent. One way to save money on the Imitrex (sumatriptan) retail cost regardless of income and insurance status is to use Imitrex coupons or discount cards from RXCoupons. Use our Sumatriptan coupons at your online pharmacy and receive up to 75% off the sale price each time you refill your prescription.

General information about Imitrex (sumatriptan)

Imitrex (sumatriptan) is an anti-migraine agent. Its active ingredient (sumatriptan) helps reduce nausea and fear of light associated with migraine attacks.

The activity of the drug begins in about half an hour after administration.

General information about Imitrex (sumatriptan) indications

Imitrex (sumatriptan) effectively copes with migraines (migraine with or without aura).

General information about Imitrex (sumatriptan) dosage

Imitrex (sumatriptan) is intended for oral use. It is recommended to take the tablet as quickly as possible after the migraine headache begins. Swallow whole tablets (without breaking), drink plenty of water.

The usual dose to get relief from migraine headaches is 100 mg once daily. Sometimes the effective dose may be less than 100 mg. The second dose is recommended to be taken the next day in order to reduce the intensity of symptoms. The interval between the doses should be not less than two hours. The maximum daily dose of sumatriptan is no more than 300 mg.

If the symptoms of migraine do not disappear, patients should consult the doctor and change the therapy plan.

General information about Imitrex (sumatriptan) contraindications

This drug is not recommended for use in case of hypersensitivity to any components. In addition, main contraindications include hemiplegic, basilar and ocular migraine. It is not recommended to use sumatriptan in CHD, angina pectoris, myocardial infarction, uncontrolled hypertension.

Imitrex is absolutely contraindicated in patients with occlusive peripheral arterial disease, transient ischemic attack, renal or hepatic insufficiency, congenital galactosemia, glucose-galactose malabsorption, lactose intolerance.

Sumatriptan is not used in the treatment of patients younger than 18 years old and older than 65 years old, as well as during pregnancy and lactation.

In addition, Imitrex should not be used with ergotamine and its derivatives (24 h after the last dose), as well as with monoamine oxidase inhibitors (within two weeks after discontinuation of therapy).

General information about Imitrex (sumatriptan) side effects

The drug can cause dizziness, drowsiness, increase in blood pressure, dyspnea, nasal bleeding, irritation and burning sensation in the throat and nasal cavity. Some patients are faced with nausea and vomiting.

Also, sumatriptan can cause pain in various parts of the body, allergic reactions, seizures, tremor, nystagmus, dystonia, etc.

General information about Imitrex (sumatriptan) during pregnancy and lactation

Sumatriptan is contraindicated during pregnancy. Caution should be used during lactation. It is recommended to discontinue breastfeeding for 24 hours after taking sumatriptan.

General information about Imitrex (sumatriptan) interactions

MAO inhibitors lead to an increase in the plasma levels of sumatriptan. These agents may cause severe hyperthermia, paroxysmal attacks. The interval between any of these drugs should be at least 14 days.

SSRIs may cause weakness, hyperreflexia, incoordination.

Ergotamine and other medicines containing ergotamine may lead to vasospasm. The interval between any of these drugs should be at least 24 h.

Imitrex (sumatriptan) special instructions

Imitrex is not prescribed for migraine prophylaxis.

Patients with cardiovascular disease, postmenopausal women, and patients with coronary artery disease risk factors need systematic monitoring.

It is not recommended to breastfeed within the first 24 hours after taking the drug.

Patients should clarify the diagnosis if no major effects are noted.

It must be borne in mind that patients suffering from migraine headaches are at risk of stroke or transient ischemic attacks.

During the period of treatment, patients should refrain from potentially hazardous activities and work that requires high concentration of attention.

Comments are closed.